The 8 Most-Studied Recovery Peptides in Preclinical Research
Tissue repair research has expanded rapidly in the last decade, with several peptides emerging as consistent subjects of preclinical investigation. Below are the 8 most studied, ranked by volume of published preclinical literature and research demand growth.
1. BPC-157 — Gastric Pentadecapeptide (SOMA Line)
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. It is the most studied peptide for tissue repair in preclinical research, with hundreds of published rodent studies. Preclinical data shows accelerated tendon-to-bone healing, promotion of angiogenesis, and gut barrier repair in animal models. CAS: 137525-51-0 · M.W.: 1419.53 g/mol · Available in 5 mg vials.
2. TB-500 (Thymosin Beta-4 Fragment) — SOMA Line
TB-500 is a synthetic analogue of the naturally occurring peptide Thymosin Beta-4, studied for its role in actin regulation and cellular migration. Preclinical studies report accelerated muscle repair, reduced inflammation, and improved wound healing in rodent models. It is frequently paired with BPC-157 in research protocols. CAS: 77591-33-4 · M.W.: 4963.44 g/mol · Available in 5 mg vials.
3. BPC-157 + TB-500 Blend — SOMA Line
The BPC-157 and TB-500 combination is the most common dual-peptide protocol in preclinical recovery research. The two compounds act through complementary pathways — BPC-157 via nitric oxide and growth factor upregulation, TB-500 via actin polymerization and anti-inflammatory cytokine modulation. Rainbow Peptide offers a pre-measured 10 mg blend for research convenience.
4. GHK-Cu (Copper Tripeptide) — AURA Line
GHK-Cu is a naturally occurring copper-binding tripeptide studied extensively for wound healing, collagen synthesis, and skin regeneration. Preclinical research demonstrates upregulation of collagen I and III, promotion of angiogenesis, and anti-inflammatory effects in dermal tissue models. It is the fastest-growing research peptide by demand in 2025. CAS: 89030-95-5 · Available in 200 mg vials.
5. KPV — Tripeptide Anti-Inflammatory (REGENERIS Line)
KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-MSH studied for anti-inflammatory and gut barrier protective effects. Preclinical data shows reduction of intestinal inflammation in IBD models and modulation of NF-κB signaling pathways. It is frequently studied alongside BPC-157 in gastrointestinal repair contexts. CAS: 13147-98-3 · Available in 50 mg vials.
6. ARA-290 — EPO Peptide Mimetic (REGENERIS Line)
ARA-290 is a non-hematopoietic analogue of erythropoietin studied for tissue protection and anti-inflammatory effects without the hematopoietic side effects of full EPO. Preclinical models show neuroprotection, reduced inflammatory cytokine expression, and tissue repair signaling. CAS: 1208243-50-8 · Available in 5 mg vials.
7. SS-31 (Elamipretide) — Mitochondria-Targeting (REGENERIS Line)
SS-31 is a mitochondria-targeted peptide studied for cellular energy restoration and oxidative stress reduction. Preclinical research demonstrates improved mitochondrial function in cardiac, renal, and skeletal muscle tissue models — making it relevant to recovery contexts where cellular energy metabolism is impaired. CAS: 736992-21-5 · Available in 5 mg vials.
8. AOD-9604 — Lipolytic hGH Fragment (SOMA Line)
AOD-9604 is a fragment of human growth hormone (hGH176-191) studied for lipolysis and fat metabolism in preclinical models. It is also being investigated for cartilage repair effects, with animal studies suggesting proteoglycan synthesis stimulation in osteoarthritic joint models. CAS: 221231-10-3 · Available in 5 mg vials.
Comparison Table: Recovery Peptides at a Glance
| Peptide | Primary Research Area | Mechanism | Purity | Format |
|---|---|---|---|---|
| BPC-157 | Tendon, gut, angiogenesis | NO, growth factors | ≥98% HPLC | 5 mg vial |
| TB-500 | Muscle, inflammation | Actin / Tβ4 pathway | ≥98% HPLC | 5 mg vial |
| BPC+TB Blend | Combined repair | Dual pathway | ≥98% HPLC | 10 mg blend |
| GHK-Cu | Skin, wound, collagen | Copper chelation | ≥98% HPLC | 200 mg vial |
| KPV | Gut, inflammation | NF-κB inhibition | ≥98% HPLC | 50 mg vial |
| ARA-290 | Tissue protection | EPO receptor (EPOR) | ≥98% HPLC | 5 mg vial |
| SS-31 | Mitochondrial function | Cardiolipin binding | ≥98% HPLC | 5 mg vial |
| AOD-9604 | Lipolysis, cartilage | hGH fragment | ≥98% HPLC | 5 mg vial |
Frequently Asked Questions
What peptides are most studied for tissue recovery?
The most studied peptides for tissue recovery in preclinical research are BPC-157, TB-500, GHK-Cu, and KPV. BPC-157 and TB-500 have the largest volume of published animal studies and are the most frequently sourced recovery peptides in 2025.
What is the difference between BPC-157 and TB-500?
BPC-157 acts primarily through nitric oxide signaling and upregulation of growth factors like EGF and HGF, with strong gastrointestinal and tendon repair data. TB-500 acts through actin polymerization modulation and anti-inflammatory cytokine pathways, with stronger data in muscle and systemic repair contexts. Many researchers use both in combination.
Are these peptides approved for human use?
No. All peptides listed here are For Research Use Only (RUO). They are not FDA-approved therapeutic agents and are not intended for human consumption. Rainbow Peptide sells exclusively to qualified researchers for lawful laboratory research purposes.
Summary
The 8 most studied peptides for recovery research in 2025 are BPC-157, TB-500, the BPC-157+TB-500 blend, GHK-Cu, KPV, ARA-290, SS-31, and AOD-9604. Each targets distinct pathways in tissue repair, inflammation, and cellular regeneration. All are available from Rainbow Peptide in research-grade, HPLC-verified formulations with Certificate of Analysis. For Research Use Only.
Browse Recovery Peptides →